173 related articles for article (PubMed ID: 6177034)
21. [Improvements in quality of life and survival of patients with T4 gastric cancer which invaded organs after multivisceral resections through the extension of palliative gastrectomy and post-operative chemotherapy].
Fujisaki S; Takashina M; Tomita R; Takayama T
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1881-4. PubMed ID: 17212135
[TBL] [Abstract][Full Text] [Related]
22. Result of 11,946 gastric cancer treatment with immunochemosurgery.
Kim JP; Lee JH; Yu HJ; Yang HK
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():206-14. PubMed ID: 10895156
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatment for advanced gastric cancer.
Maekawa S; Saku M; Maehara Y; Sadanaga N; Ikejiri K; Anai H; Kuwano H; Sugimachi K
Hepatogastroenterology; 1996; 43(7):178-86. PubMed ID: 8682459
[TBL] [Abstract][Full Text] [Related]
24. [Diagnosis, staging and therapy of gastric cancer].
Menges M
Z Gastroenterol; 2004 Aug; 42(8):767-73. PubMed ID: 15314730
[TBL] [Abstract][Full Text] [Related]
25. Early gastric cancer in the remnant stomach.
Takeda J; Toyonaga A; Koufuji K; Kodama I; Aoyagi K; Yano S; Ohta J; Shirozu K
Hepatogastroenterology; 1998; 45(23):1907-11. PubMed ID: 9840174
[TBL] [Abstract][Full Text] [Related]
26. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
27. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
28. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
29. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
Isozaki H; Tanaka N; Okajima K
Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
[TBL] [Abstract][Full Text] [Related]
30. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
31. The value of D1 lymphadenectomy as prognostic marker in gastric cancer.
Diaz de Liaño A; Ciga MA; Oteiza F; Aizcorbe M; Cobo F; Trujillo R; Nuin MA
Hepatogastroenterology; 2001; 48(39):895-8. PubMed ID: 11462951
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant and neoadjuvant therapy for gastric cancer.
Gonzalez RJ; Mansfield PF
Surg Clin North Am; 2005 Oct; 85(5):1033-51, viii. PubMed ID: 16139035
[TBL] [Abstract][Full Text] [Related]
33. Gastric carcinoma confined to the muscularis propria: how can we detect, evaluate, and cure intermediate-stage carcinoma of the stomach?
Nakamura K; Kamei T; Ohtomo N; Kinukawa N; Tanaka M
Am J Gastroenterol; 1999 Aug; 94(8):2251-5. PubMed ID: 10445558
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopically-assisted palliative total gastrectomy in patients with stage IV or metastatic gastric cancer: is it worthwhile?
Du J; Li J; Li Y; Ji G; Yang Z; Gao Z; Zheng J
Hepatogastroenterology; 2008; 55(86-87):1908-12. PubMed ID: 19102420
[TBL] [Abstract][Full Text] [Related]
35. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Kim S
Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
[TBL] [Abstract][Full Text] [Related]
36. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
Ausch C; Rosen HR; Schiessel R
Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features, surgical management, and disease outcome of perforated gastric cancer.
Jwo SC; Chien RN; Chao TC; Chen HY; Lin CY
J Surg Oncol; 2005 Sep; 91(4):219-25. PubMed ID: 16121341
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and clinical evaluation of patients with T2 gastric cancer.
Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathological characteristics and prognosis of remnant stomach cancer--report of 45 cases].
Xu DK; Zhao P; Wang CF; Shao YF; Lin HW; Tian YT
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):852-4. PubMed ID: 17416009
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic strategy for scirrhous type gastric cancer.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Hepatogastroenterology; 2005; 52(61):314-8. PubMed ID: 15783058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
